Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Koehler

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
The Lancet. Infectious Diseases|December 17, 2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidancePhilipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 28, 2021
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical MycologyJuergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, et al.
Emerging Infectious Diseases|February 4, 2021
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020Jon Salmanton-García, Rosanne Sprute, Jannik Stemler, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2020
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020Max Augustin, Philipp Schommers, Isabelle Suárez, et al.
Immunity|December 9, 2020
Low-Avidity CD4<sup>+</sup> T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19Petra Bacher, Elisa Rosati, Daniela Esser, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2023
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variantsNicola Giesen, Elena Busch, Enrico Schalk, et al.
Immunity|August 19, 2022
The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccinationCarina Saggau, Gabriela Rios Martini, Elisa Rosati, et al.
The Lancet Regional Health. Europe|February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignanciesMichael Sandherr, Jannik Stemler, Enrico Schalk, et al.
Vaccine|November 2, 2023
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)Julia M Neuhann, Jannik Stemler, Antonio J Carcas, et al.
Blood Advances|November 8, 2021
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWPAlessandro Busca, Jon Salmanton-García, Paolo Corradini, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
The Lancet. Infectious Diseases|December 17, 2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidancePhilipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 28, 2021
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical MycologyJuergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, et al.
Emerging Infectious Diseases|February 4, 2021
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020Jon Salmanton-García, Rosanne Sprute, Jannik Stemler, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2020
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020Max Augustin, Philipp Schommers, Isabelle Suárez, et al.
Immunity|December 9, 2020
Low-Avidity CD4<sup>+</sup> T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19Petra Bacher, Elisa Rosati, Daniela Esser, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2023
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variantsNicola Giesen, Elena Busch, Enrico Schalk, et al.
Immunity|August 19, 2022
The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccinationCarina Saggau, Gabriela Rios Martini, Elisa Rosati, et al.
The Lancet Regional Health. Europe|February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignanciesMichael Sandherr, Jannik Stemler, Enrico Schalk, et al.
Vaccine|November 2, 2023
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)Julia M Neuhann, Jannik Stemler, Antonio J Carcas, et al.
Blood Advances|November 8, 2021
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWPAlessandro Busca, Jon Salmanton-García, Paolo Corradini, et al.
Pageof 13